183 related articles for article (PubMed ID: 33356555)
1. Considerations in the development and validation of real-time quantitative polymerase chain reaction and its application in regulated bioanalysis to characterize the cellular kinetics of CAR-T products in clinical studies.
Yang TY; Doddareddy R
Bioanalysis; 2021 Jan; 13(2):115-128. PubMed ID: 33356555
[TBL] [Abstract][Full Text] [Related]
2. Bioanalytical Methods for Characterization of CAR-T Cellular Kinetics: Comparison of PCR Assays and Matrices.
Masilamani M; Jawa V; Dai Y; Das R; Park A; Lamba M; Wu F; Zheng X; Lu E; Gleason C; Mack T; Mora J; Surapaneni S
Clin Pharmacol Ther; 2023 Sep; 114(3):664-672. PubMed ID: 37422675
[TBL] [Abstract][Full Text] [Related]
3. Insights on Droplet Digital PCR-Based Cellular Kinetics and Biodistribution Assay Support for CAR-T Cell Therapy.
Sugimoto H; Chen S; Minembe JP; Chouitar J; He X; Wang H; Fang X; Qian MG
AAPS J; 2021 Mar; 23(2):36. PubMed ID: 33655393
[TBL] [Abstract][Full Text] [Related]
4. Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell products.
Murphy LA; Marians RC; Miller K; Brenton MD; Mallo RLV; Kohler ME; Fry TJ; Winters AC
Cytotherapy; 2023 Jan; 25(1):94-102. PubMed ID: 36253252
[TBL] [Abstract][Full Text] [Related]
5. Quantitative PCR methodology with a volume-based unit for the sophisticated cellular kinetic evaluation of chimeric antigen receptor T cells.
Yamamoto S; Matsumoto SI; Goto A; Ugajin M; Nakayama M; Moriya Y; Hirabayashi H
Sci Rep; 2020 Oct; 10(1):17884. PubMed ID: 33087808
[TBL] [Abstract][Full Text] [Related]
6. 2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (
Corsaro B; Yang TY; Murphy R; Sonderegger I; Exley A; Bertholet S; Dakappagari N; Dessy F; Garofolo F; Kierstead L; Koch H; Sarikonda G; Savoie N; Siggers R; Solstad T; Lu Y; Milton M; Marshall JC; DelCarpini J; Gorovits B; Gupta S; Jesaitis L; Kamerud J; Kromminga A; Ma A; McNally J; Yan H; Wu B; Verthelyi D; Kirshner S; Pedras-Vasconcelos J; Rajadhyaksha M; Staack RF; Cherry E; Cludts I; Dahlbäck M; Gunn GR; Ishii-Watabe A; Jawa V; Kubiak R; Partridge M; Petrillo M; Pine SO; Poetzl J; Song S; Stebbins C; Wu Y; Zhang L; Kar S; Liang M; Abhari MR; Schweighardt B; Stubenrauch K; Xu Y
Bioanalysis; 2021 Mar; 13(6):415-463. PubMed ID: 33533276
[TBL] [Abstract][Full Text] [Related]
7. Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells in Humans.
Liu C; Ayyar VS; Zheng X; Chen W; Zheng S; Mody H; Wang W; Heald D; Singh AP; Cao Y
Clin Pharmacol Ther; 2021 Mar; 109(3):716-727. PubMed ID: 33002189
[TBL] [Abstract][Full Text] [Related]
8. Detection and Quantification of Chimeric Antigen Receptor Transgene Copy Number by Droplet Digital PCR versus Real-Time PCR.
Lou Y; Chen C; Long X; Gu J; Xiao M; Wang D; Zhou X; Li T; Hong Z; Li C; Zhou J; Chen L
J Mol Diagn; 2020 May; 22(5):699-707. PubMed ID: 32409121
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of tisagenlecleucel transgene DNA using a quantitative polymerase chain reaction assay.
Davis L; Riccitelli N; Valencia N; Ch'en IL; Tangri S; Brogdon JL; Kalfoglou C; Mueller KT; Pollner R
Mol Ther Methods Clin Dev; 2021 Mar; 20():535-541. PubMed ID: 33614827
[TBL] [Abstract][Full Text] [Related]
10. Monitoring CAR-T cell kinetics in clinical trials by multiparametric flow cytometry: Benefits and challenges.
Sarikonda G; Pahuja A; Kalfoglou C; Burns K; Nguyen K; Ch'en IL; Pollner R; Tangri S; Dakappagari N
Cytometry B Clin Cytom; 2021 Jan; 100(1):72-78. PubMed ID: 32573972
[TBL] [Abstract][Full Text] [Related]
11. Sensitive detection of integrated and free transcripts in chimeric antigen receptor T-cell manufactured cell products using droplet digital polymerase chain reaction.
Wiltshire TD; Milosevic D; Jacob EK; Grebe SK; Dietz AB
Cytotherapy; 2021 May; 23(5):452-458. PubMed ID: 33715950
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a Quantitative Polymerase Chain Reaction Assay for Monitoring Chimeric Antigen Receptor T Cells in Peripheral Blood.
Wang H; Du X; Chen WH; Lou J; Xiao HL; Pan YM; Chen H; An N; Zhang QX
Transplant Proc; 2018; 50(1):104-109. PubMed ID: 29407291
[TBL] [Abstract][Full Text] [Related]
13. 2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness (
Loo L; Harris S; Milton M; Meena ; Lembke W; Berisha F; Bertholet S; Dessy F; Dodge R; Fang X; Fiscella M; Garofolo F; Gorovits B; Gupta S; Jawa V; Ishii-Watabe A; Long B; Lu Y; Mack T; McGuire K; Nolan K; Pan L; Potthoff B; Purushothama S; Smith D; Solstad T; Sonderegger I; Taddeo F; Tangri S; Wagner L; Wu B; Xu Y; Kirshner S; Verthelyi D; Yan H; Maxfield K; Pedras-Vasconcelos J; Abhari MR; Gupta S; Wu Y; Rajadhyaksha M; Andisik M; Baltrukonis D; Cherry E; Cludts I; Gunn G; Millner AH; Jordan G; Kar S; Kubiak R; Lotz GP; Palmer R; Peng K; Poetzl J; Richards S; Savoie N; Staack RF; Stubenrauch K; Wadhwa M; Waxenecker G; Yang TY; Zhang L
Bioanalysis; 2022 Jun; 14(11):737-793. PubMed ID: 35578991
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy Using Chimeric Antigen Receptor-Engineered T Cells: A Novel Cellular Therapy with Important Implications for the Clinical Laboratory.
Thibodeaux SR; Milone MC
Clin Chem; 2019 Apr; 65(4):519-529. PubMed ID: 30593467
[TBL] [Abstract][Full Text] [Related]
15. Recommendations on qPCR/ddPCR assay validation by GCC.
Wissel M; Poirier M; Satterwhite C; Lin J; Islam R; Zimmer J; Khadang A; Zemo J; Lester T; Fjording M; Hays A; Hughes N; Garofolo F; Guilbaud R; Groeber E; Renfrew H; Colletti K; Yu M; Lin J; Fang X; Shah S; Garofolo W; Kar S; Hayes R; Pirro J; Kane C; Luna M; Xu A; Cape S; O'Dell M; Wheller R; Ritzen H; Vance J; Farley E; Matys K; Tabler E; Mylott W; Yuan M; Karnik S; Voelker T; DuBey I; Williard C; Shi J; Yamashita J
Bioanalysis; 2022 Jun; 14(12):853-863. PubMed ID: 35703321
[TBL] [Abstract][Full Text] [Related]
16. Chimeric Antigen Receptor (CAR) T Cell Therapy for Cancer. Challenges and Opportunities: An Overview.
Cortés-Hernández A; Alvarez-Salazar EK; Soldevila G
Methods Mol Biol; 2021; 2174():219-244. PubMed ID: 32813253
[TBL] [Abstract][Full Text] [Related]
17. Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology.
Qi T; McGrath K; Ranganathan R; Dotti G; Cao Y
Adv Drug Deliv Rev; 2022 Sep; 188():114421. PubMed ID: 35809868
[TBL] [Abstract][Full Text] [Related]
18. Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products.
Lu A; Liu H; Shi R; Cai Y; Ma J; Shao L; Rong V; Gkitsas N; Lei H; Highfill SL; Panch S; Stroncek DF; Jin P
J Transl Med; 2020 May; 18(1):191. PubMed ID: 32384903
[TBL] [Abstract][Full Text] [Related]
19. Chimeric antigen receptor T-cell therapy for cancer: a basic research-oriented perspective.
Han C; Kwon BS
Immunotherapy; 2018 Mar; 10(3):221-234. PubMed ID: 29370727
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy.
Nawaz W; Xu S; Li Y; Huang B; Wu X; Wu Z
Acta Biomater; 2020 Jun; 109():21-36. PubMed ID: 32294554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
